Earnings Preview: PROCEPT BioRobotics Corporation (PRCT) Q3 Earnings Expected to Decline

Core Viewpoint - The market anticipates a year-over-year decline in earnings for PROCEPT BioRobotics Corporation (PRCT) despite higher revenues, with actual results being crucial for stock price movement [1][2]. Financial Expectations - The upcoming earnings report is expected to show a quarterly loss of $0.41 per share, reflecting a year-over-year change of -2.5%, while revenues are projected to be $80.63 million, an increase of 38.1% from the previous year [3]. - The consensus EPS estimate has been revised 0.93% higher in the last 30 days, indicating a slight positive adjustment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for PROCEPT BioRobotics is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -6.67%, suggesting a bearish outlook [12]. - The stock currently holds a Zacks Rank of 3, complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, PROCEPT BioRobotics was expected to post a loss of $0.41 per share but actually reported a loss of -$0.35, achieving a surprise of +14.63% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Industry Comparison - Idexx Laboratories (IDXX), a peer in the Zacks Medical - Instruments industry, is expected to report earnings per share of $3.14 for the same quarter, reflecting a year-over-year change of +12.1% and revenues of $1.07 billion, up 9.8% from the previous year [18][19].